Elevated levels of insulin-like growth factor binding protein-2 (IGFBP-2) have been linked with the development of dementia and Alzheimer’s disease (AD) and poor cognitive function, according to research presented at EAN 2019.
Elevated levels of insulin-like growth factor binding protein-2 (IGFBP-2) have been linked with the development of dementia and Alzheimer’s disease (AD) and poor cognitive function, according to research presented at EAN 2019.